Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Codexis, Inc. v. EnzymeWorks, Inc., No. 18-1655 (Fed. Cir. Feb. 8, 2019)

Affirmed in Part
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 18-1655
Decided
February 8, 2019
Judge
Per curiam
Document
Nonprecedential Opinion
Length
8 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

EnzymeWorks, Inc., Suzhou Hanmei Biotechnology Co., d/b/a EnzymeWorks, Inc. (China), Junhua Tao, and Andrew Tao (collectively “EnzymeWorks”) appeal from or- ders of the U.S. District Court for the Northern District of California. The district court impos ed sanctions on En- zymeWorks’s counsel for unreasonably multiplying the proceedings and violating the local rules (“Sanctions Or- der”). T he district court also held EnzymeWorks in con- tempt of a district court protective order and imposed sanctions for violating the order (“Contempt Order”).